Generic Semaglutide Arrives in Canadian Pharmacies This Week
Cheaper versions of Ozempic and Wegovy hit shelves, potentially slashing costs for diabetes and weight-loss patients.
Two generic versions of semaglutide are rolling into Canadian pharmacies this week — meaning patients paying for Ozempic or Wegovy could soon access the same medication at roughly one-third the cost.
Apotex, a Toronto-based manufacturer, began shipping its generic semaglutide on Tuesday. India-based Dr. Reddy's said its version has already arrived at select pharmacies and will be available more widely across the country within days.
Health Canada approved both generics about three weeks ago. They're identical to the brand-name versions but at a fraction of the price. Ozempic and Wegovy currently cost hundreds of dollars monthly — sometimes over $450 depending on dosage.
Apotex's generic is priced at approximately one-third of brand-name Ozempic. Dr. Reddy's hasn't disclosed exact pricing but says it will be "competitive." Under Canadian pharmaceutical pricing rules, generics typically cost at least 50 per cent less than the brand name — but manufacturers can price lower.
For now, the biggest impact will be on patients paying out of pocket. Provincial public formularies and private insurance plans will take time to add the new products to their coverage lists. Mina Tadrous, a pharmaceutical policy expert at the University of Toronto, said the public interest in cheaper semaglutide is "a bit unprecedented."
Pharmacists will be key guides for navigating which version is covered by individual insurance plans. Availability may vary by province and pharmacy as products move through the supply chain, so calling ahead makes sense.